Read + Share
Amedeo Smart
Independent Medical Education
Bruno G, Donnarumma B, Inverardi A, Buonpensiero P, et al. Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. Pediatr Pulmonol 2021;56:1806-1808.PMID: 33684256
Email
LinkedIn
Facebook
Twitter
Privacy Policy